Diabetes type1 Clinical Trials

8 recruiting

Diabetes type1 Trials at a Glance

8 actively recruiting trials for diabetes type1 are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Charlestown, Caen, and Chapel Hill. Lead sponsors running diabetes type1 studies include Massachusetts General Hospital, Centre Hospitalier Universitaire de la Réunion, and Centre Hospitalier Universitaire de Nice.

Browse diabetes type1 trials by phase

Treatments under study

About Diabetes type1 Clinical Trials

Looking for clinical trials for Diabetes type1? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes type1 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes type1 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Diabetes MellitusType 1 DiabetesDiabetes type1+1 more
Massachusetts General Hospital100 enrolled1 locationNCT05866536
Recruiting
Phase 2

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

Diabetes Mellitus, Type 1Diabetes type1Autoimmune Diabetes
Massachusetts General Hospital150 enrolled1 locationNCT05180591
Recruiting
Not Applicable

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

Diabetes MellitusDistress, EmotionalDiabetes Mellitus, Type 1+2 more
University of North Carolina, Chapel Hill200 enrolled1 locationNCT06405373
Recruiting

Exploration of Health Literacy in Diabetes in Reunion Island and France

Diabetes Type 2Diabetes type1Diabetes, Gestational
Centre Hospitalier Universitaire de la Réunion1,350 enrolled2 locationsNCT06437782
Recruiting
Phase 2

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

ObesityDiabetes type1
Yale University54 enrolled1 locationNCT06411210
Recruiting
Not Applicable

Impact of Gravity on Cardiac Hemodynamics

HealthyDiabetes type1
University Hospital, Caen32 enrolled1 locationNCT06190756
Recruiting

T1D Closed-loop and Physical Activity

Diabetes type1
Centre Hospitalier Universitaire de Nice65 enrolled1 locationNCT06460558
Recruiting

Host-microbiota-environment Interactions

Inflammatory Bowel DiseasesDiabetes type1Juvenile Idiopathic Arthritis
University Hospital, Clermont-Ferrand60 enrolled1 locationNCT05176795